about
Non-Invasive Brain Stimulation in Conversion (Functional) Weakness and Paralysis: A Systematic Review and Future PerspectivesAgomelatine and hepatotoxicity: implications of cumulated data derived from spontaneous reports of adverse drug reactions.Risk of bleeding related to selective and non-selective serotonergic antidepressants: a case/non-case approach using data from two pharmacovigilance databases.Hepatotoxicity associated with agomelatine and other antidepressants: Disproportionality analysis using pooled pharmacovigilance data from the Uppsala Monitoring Centre.Linking Annual Prescription Volume of Antidepressants to Corresponding Web Search Query Data: A Possible Proxy for Medical Prescription Behavior?Desomorphine goes "crocodile".Abuse liability of flupirtine revisited: implications of spontaneous reports of adverse drug reactions.Periventricular white matter lesion and incomplete MRZ reaction in a male patient with anti-N-methyl-D-aspartate receptor encephalitis presenting with dysphoric mania.Association between haemorrhages and treatment with selective and non-selective serotonergic antidepressants: Possible implications of quantitative signal detection.Drug-Induced Liver Injury Associated With Antidepressive Psychopharmacotherapy: An Explorative Assessment Based on Quantitative Signal Detection Using Different MedDRA Terms.Baseline brain perfusion and brain structure in patients with major depression: a multimodal magnetic resonance imaging study.Sensorimotor dysfunction of grasping in schizophrenia: a side effect of antipsychotic treatment?Sensitivity of Quantitative Signal Detection in Regards to Pharmacological NeuroenhancementCerebrospinal fluid biomarker candidates of schizophrenia: where do we stand?Cerebral Amyloidal Angiopathy--a disease with implications for neurology and psychiatry.Safety of electroconvulsive therapy in the presence of cranial metallic objects.Safety and tolerability of agomelatine: focus on hepatotoxicity.No effects of pulsed high-frequency electromagnetic fields on heart rate variability during human sleep.Sources of unwanted variability in measurement and description of skin surface topography.[Sacroiliitis in familial Mediterranean fever]Lack of DifferentiationBrain activity to transitional objects in patients with borderline personality disorder."Krokodil":revival of an old drug with new problems.Correspondence (letter to the editor): Prophylactic role of aspirin.From Imaging the Brain to Imaging the Retina: Optical Coherence Tomography (OCT) in Schizophrenia.Better risk assessment for individual substances.Self-inflicted testicular amputation in first lysergic acid diethylamide use.Intracortical excitability is modulated by a norepinephrine-reuptake inhibitor as measured with paired-pulse transcranial magnetic stimulation.Sweet's syndrome and polyserositis with clozapine.Drug safety and adverse drug reaction reporting behavior related to outpatient opioid replacement therapy: Results from a survey among physicians.[Nephrotoxicity and long-term treatment with lithium].Donepezil and flight simulator performance: effects on retention of complex skills.Complete dopamine D2 receptor occupancy without extrapyramidal side effects under benperidol.Aripiprazole and Parkinson's disease psychosis.Ziprasidone in Parkinson's disease psychosis.Elevated quetiapine serum concentrations in a patient treated concomitantly with doxepin, lorazepam, and pantoprazole.Acute psychosis with a mediastinal carcinoma metastasis.Anterior limbic alpha-like activity: a low resolution electromagnetic tomography study with lorazepam challenge.Retinal changes in patients with major depressive disorder - A controlled optical coherence tomography study.Successful Treatment of Major Depressive Disorder With Add-On Buprenorphine in a Patient With Previous Nonresponse to Standard Antidepressants.
P50
Q26749987-25399430-3518-4EF7-9362-8CEF55A9CF4CQ30662760-178F9258-679A-4A30-8108-4C2A139F7F5DQ30868224-C69447EA-4047-4A51-A428-C72F8A8C4B5EQ30887490-0557053C-6B8C-4680-99A7-A2A8E1FF9EBBQ30992579-9CB8FE34-D344-491B-8C41-C22B31F1F109Q34318001-820054C0-8408-409F-85C3-C5859859AD10Q34371285-AE370E63-168F-4880-8BE8-38EE7DB70DB3Q34473875-7E94F115-B049-4F0A-ACBE-DDDAACF39DFAQ35712744-135AF0DF-8652-4A92-B767-625554E9171FQ35809210-65B36314-FD08-45DB-9F32-9EC816C05FD5Q36213409-AE3E031E-1167-47A3-A7FA-BCF452F0775EQ36226422-470504BD-8737-4648-9936-5452F132C7A5Q36244289-AECC2663-2F7E-4180-B696-F9C2BCBD9E44Q37968946-1F87163D-ED20-47BC-B6D0-13F00D436C73Q38104868-688938CE-BDE1-4DD7-965E-B2E47BD8DBE9Q38189596-8A084437-F410-41AD-A871-D0CBF8669650Q38254281-3285569C-F70D-4EBE-AACB-0A93D3AE9C02Q39479640-8B85F2EF-55DE-42D2-815F-46616754E870Q40383725-2F6BBE6F-F841-4C39-AB2D-784F48DEACDEQ40742633-8664A6E3-A6E8-4D3F-9A57-DEAC74A79555Q41762904-A46F54D1-A40D-45C3-A66C-EB341D62AAA6Q42377122-ABF0DDFA-F730-4446-B794-E1B1FA42E6FBQ43063626-63CD8DBD-703E-4F4F-88EE-C4298B3A8B58Q43071197-A575ED58-C0AC-4340-87D4-F6CE4B5BC1CEQ43126101-B8E1CBBA-5976-4CE5-9E7C-97A588228B60Q43180913-648DC0ED-D4CC-4A7C-93CA-01E0703F740EQ44007916-D065F167-B204-4DFB-87AF-6E6A9AFB005BQ44196926-29286AA4-0888-4711-AF72-B1A999092C6FQ44201515-F890BACE-DBDF-4256-8C09-4D7CAA5D7E1BQ44342960-E9A7926C-D30E-452F-8871-A8F2C5F6B380Q44519273-C2F52462-C91F-4171-A4A4-329CEE0F613DQ44578356-D0E343F4-F89E-4799-B302-3B32F37A7684Q44717898-D223C840-C479-4A94-96D4-57336AC3258CQ44750302-C5F76915-97B2-4FE6-A3B0-05ABD172A4A3Q44756176-2BC2697A-6C9C-40D4-B38E-23977A653838Q45045079-461480D4-5B25-492F-AB0A-EFB1AAE91211Q45197963-EFAABD1C-A423-4620-8467-DC6CEDFC9630Q46406245-FDE2C88C-2F50-4312-9FE3-09F22EAAE97EQ47415108-64913C1D-1752-4DD1-906D-276612834A61Q47751282-BAC0C025-AAEE-4FED-9324-15558AFE1A96
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0002-0338-0729
@en
name
Bernhard J Connemann
@ast
Bernhard J Connemann
@en
Bernhard J Connemann
@nl
type
label
Bernhard J Connemann
@ast
Bernhard J Connemann
@en
Bernhard J Connemann
@nl
prefLabel
Bernhard J Connemann
@ast
Bernhard J Connemann
@en
Bernhard J Connemann
@nl
P106
P21
P31
P496
0000-0002-0338-0729